Xconomy National

Archives

by in
Entry Author Date Location
OvaScience Uses Stem Cells to Revive Fertility Arlene Weintraub 10/12/11 Boston
Big Pharma Attempts to Extend Own Lifespan by Activating Sirtuins Steve Dickman 09/23/11 Boston
Three Kings: Bessemer, Greylock, Summit Raising Big New Funds Gregory T. Huang 03/04/11 Boston
Editor’s Picks: Xconomy Boston’s Top 20 Stories of 2010 Gregory T. Huang 12/27/10 Boston
Glaxo Ends Resveratrol Drug Study Ryan McBride 12/01/10 Boston
Former Sirtris Execs Sell Resveratrol Via New Nonprofit, Dicerna Closes $25M Deal, ViThera Combats Gut Disease With Engineered Bacteria, & More Boston-Area Life Sciences News Rebecca Zacks 08/13/10 Boston
Christoph Westphal Resigns as Sirtris CEO, Takes Over Glaxo’s SR One Venture Arm Ryan McBride 04/21/10 Boston
Alnara Bags $35M B Round, Plans to Seek FDA Approval for Cystic Fibrosis Drug Ryan McBride 01/28/10 Boston
Xconomy Videos: Sirtris’ Westphal and Millennium’s Dunsire Talk Cures for Ills of Big Pharma Ryan McBride 11/13/09 Boston
See You There Tomorrow at Pharma’s Bet on Boston Innovation Luke Timmerman 11/03/09 Boston
European Regulators Question Antigenics and Biogen Idec Drugs, BioAssets Bags $30M in Option Deal, & More Boston-Area Life Sciences News Rebecca Zacks 10/28/09 Boston
Sirtris Advancing No. 1 Drug into Mid-Stage Clinical Trials for Type 2 Diabetes Ryan McBride 10/14/09 Boston
Genzyme Faces More Setbacks, Humedica Creating a Healthcare “Census,” Pops Back as Alkermes CEO, & More Boston-Area Life Science News Ryan McBride 09/30/09 Boston
Sirtris’ Westphal and Collaborators Launching New Nonprofit to Help People Live Longer Ryan McBride 09/24/09 Boston
Inside a Life Sciences Industry Confab: Notes from Convergence Ryan McBride 06/17/09 Boston
The Health 2.0 Hub, Boston’s Secret Entertainment Cluster, A Path to Market for Energy Innovations, Dean Kamen, and more XSITEment Robert Buderi 06/02/09 Boston
Elixir Raises $12 Million, Says Drug Trial Could Lead to Novartis Purchase Roxanne Palmer 05/19/09 Boston
GSK biotech subsidiary Tempero Pharma launched in the Boston area Ryan McBride 05/15/09 Boston
Bio Bigwigs from Boston and Beyond Gather in Cambridge to Discuss Future of Drug Development, Venture Capital, and Deals with Pharma Ryan McBride 04/08/09 Boston
Magen BioSciences Sold for $14.5M, Codon Devices Closing Doors Ryan McBride 04/03/09 Boston
Alnara Leapfrogs Into Phase III, Just Six Months After Getting Started Ryan McBride 03/25/09 Boston
New Execs for Exact, Sirtris, and Ischemix; New Deal for Biogen and Aveo; New Money for MedAptus and Claros; & More Boston-Area Life Sciences News Rebecca Zacks 03/25/09 Boston
Ex-Wyeth Exec Named Sirtris Pres. Ryan McBride 03/20/09 Boston
The Greater Boston Diabetes Cluster Ryan McBride 02/09/09 Boston
Viewers Hunt for Sirtris’ Anti-Aging Drugs After 60 Minutes Story Ryan McBride 01/27/09 Boston
Vertex Stays Put, Hydra Handed $22M, Sequenom Still Pursuing Exact Sciences Acquisition, & More Boston-Area Life Sciences News Rebecca Zacks 01/21/09 Boston
Hey Life Sciences Fans, Remember The Deals Back in 2008… Ryan McBride 01/05/09 Boston
Novartis Deal Could Boost Ascent by $200M, Ariad’s Boardroom Drama Comes to Light, Targanta Takes Another Hit, & More Boston-Area Life Sciences News Rebecca Zacks 12/10/08 Boston
Glaxo Promotes Sirtris’ Christoph Westphal to Drug Discovery Leadership Role Luke Timmerman 12/03/08 Boston
Vertex Co-Founder’s Hedge Fund RA Capital Makes Waves in Biotech Industry with Former Harvard Grad Student at Helm Ryan McBride 11/03/08 Boston
Page 1 of 2 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.